Kestra Medical Technologies, Ltd. Common Stock (KMTS)

• Market cap: $1.24B
• 1 day: -1.80%
• 5 days: -2.35%
• 1 month: -3.45%
• 3 months: 10.16%
• 6 months: 10.16%
• Year to date: 10.16%
• 1 year: 10.16%
• 5 years: 10.16%
• 10 years: 10.16%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $23 4% downside
• Avg. target: $27 12% upside
• High target: $29 21% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target	4% downside $23	Neutral Maintained	16 Apr 2025
Wolfe Research Mike Polark 67% 1-year accuracy 8 / 12 met price target	21% upside $29	Outperform Initiated	31 Mar 2025
Wells Fargo Larry Biegelsen 27% 1-year accuracy 12 / 44 met price target	16% upside $28	Overweight Initiated	31 Mar 2025
Stifel Rick Wise 30% 1-year accuracy 10 / 33 met price target	16% upside $28	Buy Initiated	31 Mar 2025
Piper Sandler Matt O'Brien 46% 1-year accuracy 23 / 50 met price target	12% upside $27	Overweight Initiated	31 Mar 2025